ACCELERATING METABOLIC HEALTH

Vision: To accelerate metabolic health by restoring the gut equilibrium, naturally.

GNUBiotics is developing a compound to reproduce the natural diversity and complexity of unique structures found in breast milk. These structures are beneficial in preventing infections and the onset of diet-induced obesity.
GNUbiotics aims at feeding the microbiome

WHAT’S NEW

NEWS AND BLOG

GNUbiotics Sciences raises CHF 2.3 million

GNUBIOTICS SCIENCES HAS RAISED CHF 2.3 MILLION AND SEEKS TO COMMERCIALISE ITS

0 comments

Discover our news

LATEST LINKS

Prof. Sonnenburg You Tube video on Gut Microbiome

 

 

 

GUT NATURALLY UNDERSTOOD

GUT NATURALLY UNDERSTOOD

Why is the GNUbiotics ingredient unique?

  • The most diverse HMO mimic product available. The more diverse the more proven efficiency.
  • Ingredient produced with no GMO or enzymatic processes. 100% Natural source.
  • Proven efficacy for microbiome modulation.

In response to the rising demand for healthier foods we are developing functional and structural mimics of Human Milk Oligosaccharides, (HMOs) for the consumer health market. Our products reproduce the natural diversity and complexity of HMOs and have been shown to be beneficial in preventing the onset of gut infection and protect against the effect of antibiotic use.


“It is extremely exciting to be able to play a role in advancing human knowledge in an area that will genuinely change lives for the better.” Richard T Laube.

MANAGEMENT TEAM

Richard T. Laube (Co-founder and Chairman). Richard brings to GNUbiotics an immense wealth of corporate leadership experience, having served as CEO of Nobel Biocare, CEO of Nestlé Nutrition and CEO of Roche Consumer Health.
  Jean-Philippe Kunz (Co-founder & CEO). Jean-Philippe is leading GNUbiotics by drawing on his 25 years’ international sale and business dev experience in consumer goods, pharmacy, nutrition and healthcare.
 Yemi Adesokan, PhD (Co-founder & CSO). Yemi is the award winning scientific driving force behind GNUbiotics. He matches his scientific knowledge with a deep understanding of how early stage start-ups in the biotech and nutrition sector operate.
 Bernardo Horta e Costa (Co-founder & CFO).  Bernardo brings investment and financial transactions skills to GNUbiotics to ensure investors’ money is wisely invested.
   Philippe Steenhout, MD Ped  (Director, Medical Affairs). Expert in paediatric nutrition and gut microbiome. Philippe has more than 25 years with Nestlé Nutrition brings an immense knowledge of medical and clinical development to GNUbiotics.
Felix Previdoli, PhD (Director, Product Manufacturing). Felix brings his 35 years of experience in large scale chemical industry to lead the manufacturing set-up for GNUbiotics.
   Mark Shepherd (Director, Marketing and Communications). Mark brings over 30 years’ experience in marketing and early consumer need understanding to help GNUbiotics work in partnership with customers to provide winning solutions.
SCIENTIFIC ADVISORY BOARD
Prof. Swanson is a world renown expert in companion animal nutrition, nutrigenomics and microbiomics. His research is focused on the effects of nutritional intervention on health outcomes, identifying mechanisms by which nutrients impact gastrointestinal microbiota, host gene expression, and host physiology, with primary emphasis on gastrointestinal health and obesity.
Prof. Dr. Richard Cummings Director, National Center for Functional Glycomics; Professor, Department of Surgery; Beth Israel Deaconess Medical Center, Harvard Medical School; Co-Founder of Selexys. (acquired by Novartis Nov 2016).
Prof. Dr. Justin Sonnenburg. Associate Professor of Microbiology and Immunology at Stanford Medical School; Co-Director at Center for Human Microbiome Studies.
Prof. Dr. Dirk Haller, Director at the Institute for Food & Health (ZIEL); Chair for Nutrition and Immunology at the Technical University of Munich; Scientist at Nestlé Research Center; Lausanne, Switzerland.

 

PRODUCT PIPELINE: MIMICS OF HUMAN MILK OLIGOSACCHARIDES MIX

A new approach: modulating the microbiome with a natural mechanism of action.

How it works: The GNUbiotics ingredient in the food or the milk, travels intact through the stomach to the gut. Once there its unique diversity helps it find and feed specific good bugs in the microbiome. It then balances the microbiome by selectively promoting the good bugs and starving the bad bugs. This could reinforce the immune defenses, calm gut inflammations and transform stored fats for elimination.    Click the video below to see how it works.

 

 

GNU 100 – PET FOOD oligosaccharide mix

More than 50% of pets are overweight, therefore our first product candidate will address this obesity epidemic. GNU 100 protects the gut from external aggressions and prevents excessive weight gain.

GNU 200 – HMO mimic

GNU 200 is a natural ingredient with a high structural diversity that mimics Human Milk Oligosaccharide, targeted at infant formula manufacturers to address digestive issues due to the lack of natural sugar-diversity in infant formula.

  

OUR PARTNERS

This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 808639

GET IN TOUCH

GnuBiotics Sciences Sàrl
Rte de l’Ile-au-Bois 1A CH – 1870 Monthey
Mail: info@gnubiotics.com
Tel: +41 79 906 92 27